1MD Nutrition GlucoseMD
A seven-ingredient glucose formula built on 500mg of berberine plus CinSulin, a patented Cassia cinnamon extract, with gymnema and chromium, at $54 with a 90-day money-back guarantee. The berberine dose is real. The cinnamon is Cassia rather than Ceylon, and the headline '56% of users' figure carries a footnote you should read.
Last reviewed · researched from the manufacturer’s published pages by Tom
What’s in it
Amounts are shown only where the manufacturer publishes them. Anything without a figure is undisclosed — and for an active ingredient, an undisclosed dose is the central problem with this category.
- Berberine500 mg daily dose
A genuine research-level daily amount
- CinSulin (patented Cassia cinnamon extract)amount not published
A water-extracted Cassia cinnamon; amount not published in the description we captured
- Gymnemaamount not published
Amount not published in the description we captured
- Chromiumamount not published
Amount not published in the description we captured
- Three further ingredientsamount not published
Described as a blend of 7 carefully selected ingredients
How the manufacturer says it works
1MD describes GlucoseMD as a 100% vegan blend of seven ingredients combining 500mg of berberine with CinSulin, gymnema and chromium to help maintain healthy blood glucose, support normal glucose uptake, support pancreatic cellular function and promote cardiovascular health. It states that '56% of users experienced healthy blood glucose levels', footnoted with a note that individual results vary and that the timeline may not reflect a typical purchaser's experience.
What the evidence actually supports
500mg of berberine is a genuine research-level daily dose and 1MD publishes it as a specific figure, which many multi-ingredient formulas avoid. CinSulin is a patented water-extracted cinnamon with its own research file rather than generic cinnamon powder, and water extraction is relevant here because coumarin is poorly water-soluble — so a water extract of Cassia carries far less coumarin than the raw spice. Gymnema and chromium both have plausible glucose rationales. The 90-day money-back guarantee is generous, and the company footnotes its outcome claim rather than leaving it bare.
Where that evidence stops
Only the berberine amount is published; the other six ingredients are named without quantities, so most of a seven-ingredient formula cannot be assessed. The '56% of users' figure is a user-experience statistic, not a controlled trial result — it has no placebo comparison, and the company's own footnote concedes it may not reflect a typical purchaser. Note the cinnamon species: this is Cassia, which as a raw spice carries coumarin concerns; the water-extraction process mitigates that, but a Ceylon product avoids the question entirely. And the standing berberine warning applies — CYP3A4 inhibition raising levels of prescription medications, which matters especially in a product aimed at people likely to be on glucose-lowering drugs already.
Strengths and problems
Strengths
- Publishes 500mg of berberine as a specific daily figure — a real research-level dose
- Uses CinSulin, a patented water-extracted cinnamon with its own research, not generic powder
- Water extraction meaningfully reduces the coumarin concern that applies to raw Cassia
- Gymnema and chromium both have plausible glucose rationales
- 90-day money-back guarantee is generous
- Footnotes its outcome claim rather than presenting it bare
Problems
- Only the berberine amount is published — six of seven ingredients carry no quantity
- '56% of users' is a user statistic with no placebo comparison, and the footnote concedes it may not be typical
- The cinnamon is Cassia rather than Ceylon; the extraction mitigates coumarin but does not eliminate the question
- Berberine's CYP3A4 interaction is especially relevant here, since buyers are likely on glucose-lowering medication
- No third-party testing statement, and directions are not published
- $54 is high for a formula that quantifies one ingredient
What the manufacturer publishes
Publishes 8 of 8 standard terms.
- Intended use
- Sold as a dietary supplement, not as a treatment for any condition.
- Directions
- Not published in the description we captured.
- Warnings
- Not published in the description we captured beyond the results footnote.
- Allergens
- States 100% vegan.
- Third-party testing
- Not stated in the description we captured.
- Pricing
- $54.00 at capture.
- Subscription
- Not stated in the description we captured.
- Refunds
- Publishes a 90-day money-back guarantee.
- Shipping
- Not stated in the description we captured.
May suit
Someone wanting a multi-ingredient glucose formula with a real berberine dose and a long refund window, who will ask for the other six amounts.
Do not use if
- You take any prescription medication and have not checked interactions with a pharmacist
- You are pregnant or breastfeeding
- You take glucose-lowering medication — additive hypoglycaemia risk
- You are already on glucose-lowering medication and have not discussed this with your prescriber
Frequently asked
Does the Cassia versus Ceylon distinction matter here?
Less than usual, and it is worth understanding why. Raw Cassia cinnamon carries coumarin, which is hepatotoxic at sustained intake. CinSulin is a water extract, and coumarin is poorly water-soluble, so far less carries over. That is a genuine mitigation. A Ceylon product simply avoids the question.
What does '56% of users' actually mean?
It is a user-experience statistic, not a trial result — there is no placebo group and no control. 1MD's own footnote says individual results vary and the figure may not reflect a typical purchaser's experience. Read it as marketing with a disclaimer attached, not as evidence.
Sources
Captured . Manufacturer pages change — check the current version before relying on anything.